Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | CDK4 | P11802 | 4/20 | 0.61 |
| ▸ | CCND1 | P24385 | 4/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | CCNB2 | O95067 | 2/20 | 0.48 |
| ▸ | CDK1 | P06493 | 2/20 | 0.48 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.48 |
| ▸ | CCNB3 | Q8WWL7 | 2/20 | 0.48 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.46 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL11527287 | 0.98 | LMNA (0.62) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL11070320 | 0.92 | CDK4 (0.70) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL16476616 | 0.92 | CDK4 (0.70) | LMNAKMT2AMEN1THRBBLM | |
| Ortho-Phthalaldehyde SCHEMBL29412642 | 0.81 | LMNA (1.00) | LMNAKMT2AMEN1THRBBLM | |
| Ortho-Phthalaldehyde SCHEMBL4953869 | 0.81 | LMNA (1.00) | LMNAKMT2AMEN1THRBBLM | |
| Ortho-Phthalaldehyde SCHEMBL33393 | 0.81 | LMNA (1.00) | LMNAKMT2AMEN1THRBBLM | |
| SCHEMBL30518886 | 0.79 | TRPA1 (0.71) | LMNACDK4CCND1ALDH1A1TRPA1 | |
| SCHEMBL9072393 | 0.79 | CDK4 (0.50) | LMNAKMT2AMEN1THRBBLM | |
| Ortho-Phthalaldehyde SCHEMBL6688449 | 0.78 | LMNA (0.93) | LMNAKMT2AMEN1THRBBLM | |
| Ortho-Phthalaldehyde SCHEMBL10792496 | 0.78 | LMNA (0.93) | LMNAKMT2AMEN1THRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12478091-B2 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2025-11-25 | — | — | US | claimed |
| US-11946083-B2 | Method for the microbial production of specific natural capsaicinoids | CONAGEN INC. (US) | 2024-04-02 | — | — | US | claimed |
| EP-3765081-B1 | ANTIMICROBIAL PHOTOSENSITIZER COMPOSITION | TOEFX INC (CA) | 2023-11-22 | — | — | EP | claimed |
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | claimed |
| US-20220403427-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | CONAGEN INC. (US) | 2022-12-22 | — | — | US | claimed |
| EP-4072558-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-10-19 | — | — | EP | claimed |
| US-20220233463-A1 | LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-07-28 | — | — | US | claimed |
| EP-4017486-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | Buzzelet Development And Technologies Ltd (IL) | 2022-06-29 | — | — | EP | claimed |
| US-20220168246-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2022-06-02 | — | — | US | claimed |
| EP-3968970-A1 | LOCAL ANESTHETIC COMPRISING A TRP CHANNEL MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-03-23 | — | — | EP | claimed |
| EP-1635689-A2 | METHOD AND KIT FOR CONTROLLING BLEEDING | University of Tennessee Research Foundation (US) | 2006-03-22 | — | — | EP | claimed |
| EP-1605956-A1 | ADMINISTRATION OF CAPSAICINOIDS | Algorx Pharmaceuticals, Inc. (US) | 2005-12-21 | — | — | EP | claimed |
| US-20050020690-A1 | Infiltration of capsaicin into surgical sites and open wounds | ALGORX (US) | 2005-01-27 | — | — | US | claimed |
| US-20050019436-A1 | Injectable capsaicin | ALGORX (US) | 2005-01-27 | — | — | US | claimed |
| WO-2004093664-A2 | METHOD AND KIT FOR CONTROLLING BLEEDING | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2004-11-04 | — | — | WO | claimed |
| US-20040202735-A1 | Method and kit for controlling bleeding | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION | 2004-10-14 | — | — | US | claimed |
| WO-2004058286-A1 | ADMINISTRATION OF CAPSAICINOIDS | ALGORX PHARMACEUTICALS, INC. (US) | 2004-07-15 | — | — | WO | claimed |
| EP-1135490-A1 | HUMAN VANILLOID RECEPTORS AND THEIR USES | GLAXO GROUP LIMITED (GB) | 2001-09-26 | — | — | EP | claimed |
| WO-2000032766-A1 | HUMAN VANILLOID RECEPTORS AND THEIR USES | GLAXO GROUP LIMITED (GB) | 2000-06-08 | — | — | WO | claimed |
| US-5759358-A | ACRYLIC ACID IN THE PRESENCE OF ALDEHYDES, AMINES AND DISTILLATION | ROHM AND HAAS COMPANY (US) | 1998-06-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220403427-A1 | METHOD FOR THE MICROBIAL PRODUCTION OF SPECIFIC NATURAL CAPSAICINOIDS | TRPV1, CYP51A1, NAAA | LMNA 4430/4885KMT2A 3039/4885MEN1 4196/4885 |
| US-11946083-B2 | Method for the microbial production of specific natural capsaicinoids | TRPV1, CYP51A1, NAAA | LMNA 4430/4885KMT2A 3039/4885MEN1 4196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.